Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-18-057721

Options or other derivatives

  • Director acquired 37,583 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Szela Mary T · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-06 Grant or award : show line 1 in the form Option to purchase common stock +30,000 $11.55 2028-11-05 30,000 30,000 D
2018-11-06 Grant or award : show line 2 in the form Option to purchase common stock +7,583 $11.55 2028-11-05 7,583 7,583 D
Loading xslF345X03/doc4.xml…